Impact of antibiotic-induced dysbiosis in childhood: Effects on immunological development and the risk of chronic diseases such as asthma, allergies, and obesity
DOI:
https://doi.org/10.26820/recimundo/9.(1).enero.2025.1064-1077Palabras clave:
Dysbiosis, Antibiotics, Childhood, Immunological development, Asthma, Allergies, Obesity, Chronic diseasesResumen
Antibiotic-induced dysbiosis in childhood has significant consequences for immunological development and is associated with an increased risk of chronic diseases such as asthma, allergies, and obesity. Antibiotics alter the composition and diversity of the gut microbiome, which is crucial for the maturation of the immune system. This early alteration can affect local and systemic immunity, including the gut-lung axis. An exhaustive review of the scientific literature published in databases such as PubMed, Scopus, and Web of Science over the last 5 years was conducted. Search terms included combinations of keywords such as "dysbiosis," "antibiotics," "childhood," "immunological development," "asthma," "allergies," "obesity," and "chronic diseases." Observational studies, clinical trials, and systematic reviews that evaluated the association between antibiotic exposure in childhood, the resulting dysbiosis, and the risk of developing chronic diseases were included. Antibiotic-induced dysbiosis in childhood alters immunological development and increases the risk of asthma, allergies, and obesity. A healthy infant microbiome, crucial for immunity, is affected by antibiotics, reducing its diversity. This early dysbiosis is linked to chronic diseases. To mitigate this, rational antibiotic use, dietary modulation with prebiotics, the use of probiotics/symbiotics, and the investigation of antibiotic alternatives are recommended. An integrated approach is key for healthy immunological development and the prevention of chronic diseases.Descargas
Citas
Guarner F, Bustos Fernandez L, Cruchet S, Damião A, Maruy Saito A, Riveros Lopez JP, et al. Gut dysbiosis mediates the association between antibiotic exposure and chronic disease. Front Med [Internet]. 2024 Nov 6;11. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2024.1477882/full
Sandoval MDLPR, Pérez GTL, Ramírez MA V. Antibióticos y disbiosis. Enfermedades Infecc y Microbiol. 2021;41(3):118–22.
Calderón XM, Bioanalista A. Disbiosis en la microbiota intestinal. Rev GEN. 2022;76(1):17–23.
Neuman H, Forsythe P, Uzan A, Avni O, Koren O. Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol Rev [Internet]. 2018 Jun 25; Available from: https://academic.oup.com/femsre/advance-article/doi/10.1093/femsre/fuy018/5045017
Alhasan MM, Hölsken O, Duerr C, Helfrich S, Branzk N, Philipp A, et al. Antibiotic use during pregnancy is linked to offspring gut microbial dysbiosis, barrier disruption, and altered immunity along the gut–lung axis. Eur J Immunol [Internet]. 2023 Oct 10;53(10). Available from: https://onlinelibrary.wiley.com/doi/10.1002/eji.202350394
Jielong, Guo, Han X, Huang W, You Y, Zhan J. Gut dysbiosis during early life: causes, health outcomes, and amelioration via dietary intervention. Crit Rev Food Sci Nutr [Internet]. 2022 Sep 12;62(26):7199–221. Available from: https://www.tandfonline.com/doi/full/10.1080/10408398.2021.1912706
Turner D, Bishai J, Reshef L, Abitbol G, Focht G, Marcus D, et al. Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. Inflamm Bowel Dis [Internet]. 2020 Oct 23;26(11):1733–42. Available from: https://academic.oup.com/ibdjournal/article/26/11/1733/5675351
McDonnell L, Gilkes A, Ashworth M, Rowland V, Harries TH, Armstrong D, et al. Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes [Internet]. 2021 Jan 1;13(1). Available from: https://www.tandfonline.com/doi/full/10.1080/19490976.2020.1870402
Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H. Antibiotics as Major Disruptors of Gut Microbiota. Front Cell Infect Microbiol [Internet]. 2020 Nov 24;10. Available from: https://www.frontiersin.org/articles/10.3389/fcimb.2020.572912/full
Tramper?Stranders G, Ambro?ej D, Arcolaci A, Atanaskovic?Markovic M, Boccabella C, Bonini M, et al. Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases. Allergy [Internet]. 2021 Nov 27;76(11):3276–91. Available from: https://onlinelibrary.wiley.com/doi/10.1111/all.15046
Azad MB, Moossavi S, Owora A, Sepehri S. Early-Life Antibiotic Exposure, Gut Microbiota Development, and Predisposition to Obesity. In 2017. p. 67–80. Available from: https://karger.com/books/book/232/chapter/5159487
Principi N, Esposito S. Antibiotic administration and the development of obesity in children. Int J Antimicrob Agents [Internet]. 2016 Mar;47(3):171–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0924857916000133
Vangoitsenhoven R, Cresci GAM. Role of Microbiome and Antibiotics in Autoimmune Diseases. Nutr Clin Pract [Internet]. 2020 Jun 22;35(3):406–16. Available from: https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10489
Alfayate Miguélez S, Garcia-Marcos L. Rational use of antimicrobials in the treatment of upper airway infections. J Pediatr (Rio J) [Internet]. 2020 Mar;96:111–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0021755719306497
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol [Internet]. 2017 Aug 14;14(8):491–502. Available from: https://www.nature.com/articles/nrgastro.2017.75
Rallis D, Giapros V, Serbis A, Kosmeri C, Baltogianni M. Fighting Antimicrobial Resistance in Neonatal Intensive Care Units: Rational Use of Antibiotics in Neonatal Sepsis. Antibiotics [Internet]. 2023 Mar 3;12(3):508. Available from: https://www.mdpi.com/2079-6382/12/3/508
Queen J, Zhang J, Sears CL. Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Clostridioides difficile. Gut Microbes [Internet]. 2020 Jul 3;11(4):1092–103. Available from: https://www.tandfonline.com/doi/full/10.1080/19490976.2019.1706425
Ortiz-Mejía PF, Peña-Cordero SJ, Salazar-Torres ZK. Disbiosis intestinal, obesidad y diabetes tipo 2. Una revisión de alcance. MQRInvestigar [Internet]. 2024 Jun 7;8(2):3649–76. Available from: https://www.investigarmqr.com/ojs/index.php/mqr/article/view/1425
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Juan José Sarasti Espejo, Nathalye Stepfanye Guayasamín Calispa, Emily Sofía Bedoya Hidalgo, Ana Paula Herrera Jaramillo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
